Literature DB >> 6378954

Immunohistochemical detection of the estrogen-regulated 52,000 mol wt protein in primary breast cancers but not in normal breast and uterus.

M Garcia, G Salazar-Retana, G Richer, J Domergue, F Capony, H Pujol, F Laffargue, B Pau, H Rochefort.   

Abstract

An estrogen regulated glycoprotein of molecular weight 52,000 is released by metastatic human breast cancer cells in culture. In order to detect this protein directly in human tissues, several high affinity monoclonal antibodies were produced against the 52,000 mol wt protein. Frozen sections of human breast cancer samples were stained by the peroxidase-anti-peroxidase method using these antibodies. In 20 of 25 samples, specific immunoperoxidase staining was observed in the cytoplasm of epithelial cells with six monoclonal antibodies to the 52,000 mol wt protein. The 5 samples that were not stained contained no detectable estrogen receptor. Epithelial cells were not stained in 6 normal mammary glands collected during reduction mammoplasties and in 9 normal uteri, whether tissues were collected during the follicular or luteal phase. The demonstration that the 52,000 mol wt estrogen regulated protein is present in the cytoplasm of some primary breast cancers but absent in normal mammary tissue and uterus indicates its possible use as a tumor marker.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6378954     DOI: 10.1210/jcem-59-3-564

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  5 in total

1.  Cathepsin D in invasive ductal NOS breast carcinoma as defined by immunohistochemistry. No correlation with survival at 5 years.

Authors:  W Domagala; G Striker; A Szadowska; A Dukowicz; K Weber; M Osborn
Journal:  Am J Pathol       Date:  1992-11       Impact factor: 4.307

2.  Progestin treatment depresses estrogen receptor but not cathepsin D levels in needle aspirates of benign breast disease.

Authors:  T Maudelonde; P Lavaud; G Salazar; F Laffargue; H Rochefort
Journal:  Breast Cancer Res Treat       Date:  1991-10       Impact factor: 4.872

3.  Phosphorylation, glycosylation, and proteolytic activity of the 52-kD estrogen-induced protein secreted by MCF7 cells.

Authors:  F Capony; M Morisset; A J Barrett; J P Capony; P Broquet; F Vignon; M Chambon; P Louisot; H Rochefort
Journal:  J Cell Biol       Date:  1987-02       Impact factor: 10.539

4.  Relationship between cathepsin D, urokinase, and plasminogen activator inhibitors in malignant vs benign breast tumours.

Authors:  D Foucré; C Bouchet; K Hacène; N Pourreau-Schneider; A Gentile; P M Martin; A Desplaces; J Oglobine
Journal:  Br J Cancer       Date:  1991-11       Impact factor: 7.640

5.  Detection of P24 protein in human breast cancer: influence of receptor status and oestrogen exposure.

Authors:  L Seymour; W R Bezwoda; K Meyer; C Behr
Journal:  Br J Cancer       Date:  1990-06       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.